SiMa.ai
SiMa.ai builds a full-stack physical AI platform that combines purpose-built silicon and software to help developers deploy machine learning on real-world devices.
$150MSeries C
LeadFM
Fidelity Management & Research Company
Activity from announced rounds
Activity in this selectionprotein-capital-76af7244
Fidelity Management & Research Company is an investment adviser within Fidelity Investments, managing portfolios for investment funds and other clients, including exposure to private companies.
Fidelity’s research-led technology investing examines both public and private businesses. Its AI framework covers the computing components and infrastructure needed to run models as well as companies applying the technology, connecting private-company analysis with the wider listed market.
FMR manages capital through investment products and client mandates. A financing attributed to the manager can therefore involve fund-managed capital, rather than a standalone accelerator or a standard programme with a fixed investment offer for founders.
- Rounds participated in
- 19
- Confirmed lead rounds
- 1 16 roles undisclosed
- New companies
- 18 First participation on record · 1 follow-on
- Funding in participating rounds
- $4.9B 17 disclosed · full round size, not this investor’s share
By stage
By primary sector
3 more
Logistics1
Mobility1
Space tech1
By country
Rounds
19 in this selectionCrusoe
AI infrastructure combining GPU cloud services, managed AI tools, large-scale data centers and modular AI factories for model developers and enterprises.
>$3.9BSeries F
ParticipantLyte
Lyte develops perception systems for robots and autonomous machines used in inspection, logistics and manufacturing.
$165MSeries C
ParticipantEpicrispr Biotechnologies
Develops programmable epigenetic medicines to treat genetic diseases like FSHD
$90MSeries C
Role not disclosedXsight Labs
Fabless semiconductor company building connectivity chips for hyperscale, edge, and AI data centers
>$300MGrowth
Role not disclosedAdvanCell
AdvanCell develops targeted alpha radiopharmaceuticals for cancer using Lead-212, with integrated isotope supply and manufacturing.
$315MSeries D
Role not disclosedNearfield Instruments
Develops advanced 3D scanning probe metrology and inspection systems for semiconductor manufacturing
$380MSeries D
Role not disclosedCity Therapeutics
City Therapeutics develops RNA-interference therapeutics and an engineering platform across disease areas.
$99.5MSeries B
Role not disclosedCellCentric
Develops inobrodib, a first-in-class oral p300/CBP inhibitor for relapsed or refractory multiple myeloma
$220MSeries D
Role not disclosedAstranis
Builds and operates small GEO satellites for commercial and government communications
$450MSeries E
Role not disclosedFrore Systems
Develops advanced thermal cooling technologies for AI data centers and edge devices
$143MSeries D
Role not disclosedSHINE Technologies
Develops commercial fusion technology for neutron testing radioisotope production and fusion energy
$240MSeries E
Role not disclosedCerebras Systems
Cerebras Systems develops computing infrastructure for AI.
$1BSeries H
Role not disclosedSkyryse
Develops automated flight control systems for aircraft
$300MSeries C
Role not disclosedZipline
Provides autonomous drone delivery and logistics services
$600MSeries B
Role not disclosedWasabi Technologies
Provides cloud storage for AI-first applications
$70MEquity
Role not disclosedMirador Therapeutics
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases
$250MSeries B
Role not disclosedParabilis Medicines
Develops medicines targeting historically undruggable protein targets in cancer
$305MSeries F
Role not disclosedLyte
Lyte develops perception systems for robots and autonomous machines used in inspection, logistics and manufacturing.
$107MUndisclosed
Role not disclosed